Seongnam, South Korea

Min Sung Kim

This inventor holds 1 USPTO granted patent and 10 published patent applications and 1 EPO patent. Top assignee: Inventage Lab Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Sung Kim. Retrieved from https://idiyas.com/inventor/min-sung-kim-665ososd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Min Sung Kim - Innovator in Microparticle Technology

Introduction

Min Sung Kim is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on microparticles.

Latest Patents

Min Sung Kim holds a patent for "Microparticles containing leuprolide and method for producing the same." This invention provides a method for producing microparticles that contain leuprolide, which can be administered via injection. The microparticles are designed to lower pain due to their small size, control the release rate of leuprolide at a target site, and prevent excessive release at the initial stage. This technology enables sustained exposure to the drug, allowing it to exhibit its effects for one month or more. The microparticles are characterized by a uniform particle size and a smooth surface, ensuring a sustainable release of leuprolide over an extended period.

Career Highlights

Min Sung Kim is associated with Inventage Lab Inc., where he continues to develop innovative solutions in the pharmaceutical field. His work focuses on enhancing drug delivery methods to improve patient outcomes.

Collaborations

One of his notable collaborators is Ju Hee Kim, who works alongside him at Inventage Lab Inc. Their partnership contributes to the advancement of microparticle technology and its applications in medicine.

Conclusion

Min Sung Kim's contributions to microparticle technology represent a significant advancement in drug delivery systems. His innovative approach has the potential to improve the efficacy of treatments and enhance patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…